BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Riveiro-Barciela M, Marcos-Fosch C, Martinez-Valle F, Bronte F, Orozco O, Sanz-Pérez I, Torres D, Salcedo MT, Petta S, Esteban R, Craxi A, Buti M. Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study. World J Gastroenterol 2021; 27(30): 5112-5125 [PMID: 34497439 DOI: 10.3748/wjg.v27.i30.5112]
URL: https://www.wjgnet.com/2307-8960/full/v27/i30/5112.htm
Number Citing Articles
1
V.B. Stetseviat, N.M. Voronych-Semchenko, M.M. Bahrii, T.V. Huranych. PREDICTORS OF HEPATOCYTES CYTOLYSIS OF INSULIN RESISTANT RATS UNDER CONDITIONS OF PRE- AND POSTNATAL IODINE DEFICIENCYFiziolohichnyĭ zhurnal 2023; 69(3): 10 doi: 10.15407/fz69.03.010
2
Qian Li, Yihui Chai, Wen Li, Liancheng Guan, Yizi Fan, Yunzhi Chen. Mechanism of Simiao Decoction in the treatment of atherosclerosis based on network pharmacology prediction and molecular dockingMedicine 2023; 102(36): e35109 doi: 10.1097/MD.0000000000035109
3
R.N. Mustafin. Prospects for the use of statins in antiviral therapyClinical Microbiology and Antimicrobial Chemotherapy 2023; 25(1): 56 doi: 10.36488/cmac.2023.1.56-67
4
Atefe Ghamar Talepoor, Mehrnoosh Doroudchi. Immunosenescence in atherosclerosis: A role for chronic viral infectionsFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.945016
5
Ivan Ranković, Vladimir Milivojević, Aleksandra Pavlović Marković, Mihailo Bezmarević. Interplay between chronic hepatitis B and atherosclerosis: Innovative perspectives and theoriesWorld Journal of Gastroenterology 2022; 28(4): 497-499 doi: 10.3748/wjg.v28.i4.497